Donepezil and Memantine for Moderate-to-Severe Alzheimer's DiseaseRobert Howard, Patrick Phillips, Rupert McShane et al.|New England Journal of Medicine|2012Cited by 774
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Richard Gray, Patrick Phillips et al.|International Journal of Geriatric Psychiatry|2010Cited by 177
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Patrick Phillips, Rupert McShane et al.|The Lancet Neurology|2015Cited by 164
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trialRobert Howard, Richard Gray, Elizabeth Cort et al.|The Lancet Psychiatry|2018Cited by 66
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)Martín Knapp, Robert Howard, Derek King et al.|International Journal of Geriatric Psychiatry|2016Cited by 63